التفاصيل البيبلوغرافية
| العنوان: |
The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists |
| المؤلفون: |
van Baar, Michaël J. B., van der Aart, Annemarie B., Hoogenberg, Klaas, Joles, Jaap A., Heerspink, Hiddo J. L., van Raalte, Daniël H. |
| المصدر: |
Therapeutic Advances in Endocrinology and Metabolism ; volume 10, page 204201881986539 ; ISSN 2042-0188 2042-0196 |
| بيانات النشر: |
SAGE Publications |
| سنة النشر: |
2019 |
| مصطلحات موضوعية: |
Endocrinology, Diabetes and Metabolism |
| الوصف: |
Diabetic kidney disease (DKD) remains the main cause for chronic kidney disease (CKD) and end-stage kidney disease (ESKD) worldwide. Both CKD and ESKD lead to major increases in risk of cardiovascular disease and death in people with diabetes. Despite optimal management of lifestyle, glucose levels and hypertension, residual risk remains high, indicating that additional therapies to mitigate the burden of the disease are desired. In past decades, new treatment options for the management of diabetes have emerged, of which some have showed promising renoprotective potential. This review discusses current understanding of the renal effects of glucagon-like peptide receptor agonists and their potential use in prevention and treatment of DKD. |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1177/2042018819865398 |
| الإتاحة: |
https://doi.org/10.1177/2042018819865398Test |
| حقوق: |
http://journals.sagepub.com/page/policies/text-and-data-mining-licenseTest |
| رقم الانضمام: |
edsbas.8BE1EDDD |
| قاعدة البيانات: |
BASE |
